Nanthealth Ownership

NH
 Stock
  

USD 0.24  0.02  7.69%   

Some institutional investors establish a significant position in stocks such as Nanthealth in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Nanthealth, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Additionally, see Correlation Analysis.
  
Nanthealth maintains a total of one hundred fifteen million four hundred fourty thousand outstanding shares. Nanthealth holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how much assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Nanthealth Stock Ownership Analysis

About 58.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.51. Nanthealth had not issued any dividends in recent years. NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. Nanthealth operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 326 people. To find out more about Nanthealth contact the company at 855 949 6268 or learn more at https://nanthealth.com.

Nanthealth Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Nanthealth is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nanthealth backward and forwards among themselves. Nanthealth's institutional investor refers to the entity that pools money to purchase Nanthealth's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Highbridge Capital Management LlcCommon Shares2.2 M900 K
Vanguard Group IncCommon Shares954.9 K399 K
Atria Wealth Solutions IncCommon Shares491.9 K205 K
Geode Capital Management LlcCommon Shares408.3 K170 K
Bridgeway Capital Management LlcCommon Shares306.5 K128 K
Millennium Management LlcCommon Shares264.5 K110 K
Hartline Investment CorpCommon Shares20 K65 K
Simplex Trading LlcCall Options24.1 K10 K
Note, although Nanthealth's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Nanthealth Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nanthealth insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nanthealth's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nanthealth insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Nanthealth without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Equity Forecasting Now

   

Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Nanthealth using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Correlation Analysis. Note that the Nanthealth information on this page should be used as a complementary analysis to other Nanthealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Nanthealth Stock analysis

When running Nanthealth price analysis, check to measure Nanthealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanthealth is operating at the current time. Most of Nanthealth's value examination focuses on studying past and present price action to predict the probability of Nanthealth's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Nanthealth's price. Additionally, you may evaluate how the addition of Nanthealth to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Nanthealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nanthealth. If investors know Nanthealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nanthealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nanthealth is measured differently than its book value, which is the value of Nanthealth that is recorded on the company's balance sheet. Investors also form their own opinion of Nanthealth's value that differs from its market value or its book value, called intrinsic value, which is Nanthealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nanthealth's market value can be influenced by many factors that don't directly affect Nanthealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nanthealth's value and its price as these two are different measures arrived at by different means. Investors typically determine Nanthealth value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nanthealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.